HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Lipidology
Lipidology
The scientific study of lipids is known as lipidology. The group of organic molecules known as lipids includes fatty acids and their derivatives, which are soluble in organic solvents but insoluble in water. A class of biological macromolecules known as lipids serves a wide range of purposes in the body. Lipids are important for creating cells and fat storage. However, a concentration or build-up of them might have negative health effects and result in major complications, such as cardiac illnesses like cardiovascular disease. Hyperlipidaemia, or an excess of lipids in the blood, is the most prevalent disease.
Several lipid disorders are studies within which are lipidology, these include
- Hypercholesterolaemia
- Hyperglyceridaemia
- Hypertriglyceridaemia
- Hyperlipoproteinaemia
- Hyperchylomicronaemia
- Combined hyperlipidaemia
- Familial hypercholesterolaemia
- Diabetes mellitus
Committee Members
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United StatesSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation